The vaccination is given in a series of three intramuscular injections followed by a post-vaccination blood test to check for immunity. The first dose can be given at any time. The second dose is given 1-2 months after the first dose, and the third dose is given 6 months after the first dose. The post-vaccination blood test is recommended 1 to 2 months after the final dose.
Studies indicate that immunologic memory remains intact for at least 20 years among healthy vaccinated individuals who initiated Hepatitis B vaccination >6 months of age. The vaccine confers long-term protection against clinical illness and chronic Hepatitis B virus infection. Cellular immunity appears to persist even though antibody levels might become low or decline below detectable levels.
For persons with normal immune status who have been vaccinated, booster doses of Hepatitis B vaccine are not recommended. However, booster doses are recommended for hemodialysis patients or other immunocompromised persons.
No, the series does not need to be restarted. If the vaccine series was interrupted after the first dose, the second dose should be administered as soon as possible. The second and third doses should be separated by an interval of at least 8 weeks. If only the third dose is delayed, it should be administered as soon as possible.
Yes. No differences in immune response are observed when vaccines from different manufacturers are used to complete the vaccine series.
The post-vaccination blood test is designed to check the body's immune response to the vaccination. It informs you and your health care provider of the production of antibodies that will provide immunity to Hepatitis B. The post-vaccination blood test is most meaningful when performed 1-2 months after the final dose of the vaccination series; however, it may be done any time after the final dose.
If your post-vaccination blood test is negative, the series and post-vaccination blood test is repeated. A second negative blood test indicates that you did not develop immunity and are not protected against Hepatitis B infection.
The Hepatitis B vaccine is safe. However, a vaccine, like any medicine, is capable of causing serious problems, such as allergic reactions. The risk of Hepatitis B vaccine causing serious harm is extremely small. Most people who get Hepatitis B vaccine do not have any problems with it.
Mild problems: Soreness where the shot was given, lasting a day or two (up to about 1 person in 4); temperature of 99.9°F or higher (up to about 1 person in 15). Severe problems: Serious allergic reaction (extremely rare – about once in 1.1 million doses).
Look for any unusual condition, such as a serious allergic reaction, high fever or unusual behavior. Although extremely rare, if one were to occur, it would be within a few minutes to a few hours after the shot. Signs can include difficulty breathing, hoarseness or wheezing, hives, paleness, weakness, a fast heart beat, or dizziness. If you are experiencing any of these signs, contact your health care provider immediately.
If you have a medical condition or concern (e.g. allergy to Baker's yeast, allergic reaction to previous dose of Hepatitis B vaccine, or pregnant), you should always consult your personal health care provider for advice prior to receiving Hepatitis B vaccination. People who are moderately or severely ill at the time the shot is scheduled should usually wait until they recover before getting the Hepatitis B vaccine.
Your Unit Head will arrange for you to receive the Hepatitis B vaccination series and post-vaccination blood test through McKinley Health Center.
Unit Heads should follow the following procedure to arrange the vaccination series and the post-vaccination blood test for each employee.